Three health innovation networks were recognised for the quality of their work at last night’s HSJ Awards ceremony (Thursday 16 November 2023), which celebrates success and excellence in healthcare across the NHS.
UCLPartners won the ‘Medicines, Pharmacy & Prescribing Initiative of the Year’ award, in partnership with Barts Health Trust, North East London ICB, and Clinical Effectiveness Group (Queen Mary University of London). The award celebrated its work in specialist pharmacy-led cardiovascular risk factor management in primary care: A population health management approach.
Imperial College Health Partners received highly commended in the ‘Data-Driven Transformation Award category’ for its London Asthma Decision Support Tool (LADS). This was a collaboration with North West London ICS, South East London ICS, and Vizify.
LADS is a new NHS data tool that for the first time brings together air pollution, demographic and social deprivation data with routinely collected NHS data. This allows clinical teams to intervene much earlier in the patient pathway and improve outcomes, and also focus on identifying and investigating areas of health inequity across the capital.
Health Innovation West Midlands received highly commended in the ‘Provider Collaboration of the Year’ category for its Managing Deterioration in Care Homes Safety and Improvement Programme. This was a collaboration across local ICBs, NHS England, the West Midlands Learning Disability and Autism Self-Advocacy Network, and West Midlands Association of Directors of Adult Social Services to support care home staff in identifying, communicating, and taking action on the physical and early soft signs of health deterioration in adult residents.
Meanwhile, Health Innovation Network South London was shortlisted as a finalist in the ‘Mental Health Innovation of the Year’ category for its Early Intervention Eating Disorders (FREED) National Spread Programme.
Health Innovation Oxford and Thames Valley was also shortlisted in the ‘Medicines, Pharmacy & Prescribing Initiative of the Year’ category for its Integrated Severe Asthma Project (ISAC).
A ‘record-breaking’ 1456 entries were received for this year’s Awards, with 223 projects and individuals reaching the final shortlist, making it the biggest awards programme in the award’s 43-year history.
Major conditions like chronic cardiovascular and lung disease account for a disproportionate share of healthcare resources and are tied to inequalities. Lenus Health provide AI and digital tools to existing care pathways to improve healthcare delivery, reduce admissions and improve outcomes. We spoke to Paul McGinness, CEO and co-founder of Lenus Health to find out more. [...]
Us2.ai is a fast-growing start-up, based in Singapore but now operating worldwide, which is dedicated to tackling CVD and heart disease through pioneering Artificial Intelligence (AI). Its mission is to improve patient outcomes and expand healthcare access by making echocardiograms, the most used tool for the detection of heart risk, available to all. We spoke [...]
Dr George Harston is Chief Medical and Innovation Officer at Brainomix. He is also a Consultant Physician in Stroke and General Medicine at Oxford University Hospitals NHS Foundation Trust. The company’s innovative AI-enabled decision support tools are helping clinicians to rapidly and accurately decide the type and severity of stroke, and the most appropriate treatment. It [...]
